Silence Therapeutics (SLN) Free Cash Flow (2024 - 2026)
Silence Therapeutics (SLN) reported Free Cash Flow of -$15.6 million for Q1 2026, down 26.72% on a YoY basis from -$21.3 million in Q1 2025, and up 9.89% sequentially from -$17.3 million in Q4 2025.
Silence Therapeutics (SLN) Free Cash Flow (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Free Cash Flow data on file, last reported at -$15.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 26.72% year-over-year to -$15.6 million; the trailing twelve-month figure through Mar 2026 stood at -$65.6 million (up 7.57% YoY), and the FY2025 full-year result was -$62.4 million, up 8.1% from the prior year.
- Free Cash Flow improved to -$15.6 million in Q1 2026, from -$17.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$5.5 million in Q2 2024 to a low of -$28.2 million in Q4 2024.
- A 3-year average of -$16.2 million and a median of -$15.6 million in 2026 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 56.12% in 2025, while the deepest fall reached 296.31% in 2025.
- Tracing SLN's Free Cash Flow over 3 years: stood at -$28.2 million in 2024, then soared by 38.7% to -$17.3 million in 2025, then rose by 9.89% to -$15.6 million in 2026.
- Business Quant data shows SLN's Free Cash Flow at -$15.6 million in Q1 2026, -$17.3 million in Q4 2025, and -$11.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -15.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.60 Mn |
| Mar 31, 2026 | -15.60 Mn |
| Dec 31, 2025 | -17.32 Mn |
| Dec 31, 2025 | -17.32 Mn |
| Sep 30, 2025 | -10.95 Mn |
| Sep 30, 2025 | -10.95 Mn |
| Jun 30, 2025 | -21.77 Mn |
| Jun 30, 2025 | -21.77 Mn |
| Mar 31, 2025 | -12.31 Mn |
| Mar 31, 2025 | -12.31 Mn |
| Dec 31, 2024 | -28.25 Mn |
| Dec 31, 2024 | -28.25 Mn |
| Sep 30, 2024 | -24.96 Mn |
| Sep 30, 2024 | -24.96 Mn |
| Jun 30, 2024 | -5.49 Mn |
| Jun 30, 2024 | -5.49 Mn |
| Mar 31, 2024 | -9.14 Mn |
| Mar 31, 2024 | -9.14 Mn |